Vai direttamente al contenuto

Beta-talassemia maior (età pediatrica)

Rischi e incertezze delle emotrasfusioni

Seropositivity of hepatitis C, hepatitis B and HIV in chronically transfused β-thalassaemia major patients. (apre una nuova finestra)

Ansari SH, Shamsi TS, Khan MT, Perveen K, Farzana T, Erum S, Ansari I.

Fonte‎: J Coll Physicians Surg Pak 2012;22(9):610-1.

Indicizzato‎: PubMed 22980623

DOI‎: 09.2012/JCPSP.610611

https://www.ncbi.nlm.nih.gov/pubmed/22980623 (apre una nuova finestra)

Blood transfusion and lung function in children with thalassemia major. (apre una nuova finestra)

Bacalo A, Kivity S, Heno N, Greif Z, Greif J, Topilsky M.

Fonte‎: Chest 1992;101(2):362-5.

Indicizzato‎: PubMed 1735255

https://www.ncbi.nlm.nih.gov/pubmed/1735255 (apre una nuova finestra)

Pulmonary dysfunction in transfusion-dependent patients with thalassemia major. (apre una nuova finestra)

Carnelli V, D'Angelo E, Pecchiari M, Ligorio M, D'Angelo E.

Fonte‎: Am J Respir Crit Care Med 2003;168(2):180-4.

Indicizzato‎: PubMed 12738605

DOI‎: 10.1164/rccm.200211-1292OC

https://www.ncbi.nlm.nih.gov/pubmed/12738605 (apre una nuova finestra)

Clinical outcome of frequent exposure to Torque Teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection. (apre una nuova finestra)

Hu YW, Al-Moslih MI, Al Ali MT, Uzicanin S, Perkins H, Yi QL, Rahimi Khameneh S, Wu J, Brown EG.

Fonte‎: J Med Virol 2008;80(2):365-71.

Indicizzato‎: PubMed 18098140

DOI‎: 10.1002/jmv.21070

https://www.ncbi.nlm.nih.gov/pubmed/18098140 (apre una nuova finestra)

A prospective study for prevalence and/or development of transfusion-transmitted infections in multiply transfused thalassemia major patients. (apre una nuova finestra)

Jain R, Perkins J, Johnson ST, Desai P, Khatri A, Chudgar U, Choudhury N.

Fonte‎: Asian J Transfus Sci 2012;6(2):151-4.

Indicizzato‎: PubMed 22988380

DOI‎: 10.4103/0973-6247.98919

https://www.ncbi.nlm.nih.gov/pubmed/22988380 (apre una nuova finestra)

Prevalence of alloimmunisation in patients with beta thalassaemia major. (apre una nuova finestra)

Kosaryan M, Mahdavi MR, Roshan P, Hojjati MT.

Fonte‎: Blood Transfus 2012;10(3):396-7.

Indicizzato‎: PubMed 22395351

DOI‎: 10.2450/2012.0072-11

https://www.ncbi.nlm.nih.gov/pubmed/22395351 (apre una nuova finestra)

Post-transfusion hypertension, convulsion and intracranial haemorrhage in β-thalassemia major. (apre una nuova finestra)

Masood SA, Zaidi A.

Fonte‎: J Coll Physicians Surg Pak 2012;22(7):473-5.

Indicizzato‎: PubMed 22747874

DOI‎: 07.2012/JCPSP.473475

https://www.ncbi.nlm.nih.gov/pubmed/22747874 (apre una nuova finestra)

Marseillevirus prevalence in multitransfused patients suggests blood transmission. (apre una nuova finestra)

Popgeorgiev N, Colson P, Thuret I, Chiarioni J, Gallian P, Raoult D, Desnues C.

Fonte‎: J Clin Virol 2013;58(4):722-5.

Indicizzato‎: PubMed 24183312

DOI‎: 10.1016/j.jcv.2013.10.001

https://www.ncbi.nlm.nih.gov/pubmed/24183312 (apre una nuova finestra)

Blood transfusion transmitted infections in multiple blood transfused patients of Beta thalassaemia. (apre una nuova finestra)

Vidja PJ, Vachhani JH, Sheikh SS, Santwani PM.

Fonte‎: Indian J Hematol Blood Transfus 2011;27(2):65-9.

Indicizzato‎: PubMed 22654294

DOI‎: 10.1007/s12288-011-0057-3

https://www.ncbi.nlm.nih.gov/pubmed/22654294 (apre una nuova finestra)